Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bitopertin for persistent negative symptoms of schizophrenia (Japan phase III)
jRCT2080221370Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Bitopertin + antipsychotics with Placebo + antipsychotics (2 arms).
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080221370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221370.